Assisted conception business should be better regulated

BMJ 2006; 332 doi: 10.1136/bmj.332.7544.748-b (Published 30 March 2006)
Cite this as: BMJ 2006;332:748.3

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Andrew Cole
  1. London

    Infertility treatment in the United Kingdom is in danger of turning into an exclusive market for rich people unless it is more tightly regulated, a Harvard Business School professor has warned. Assisted reproduction is big business, but it is not regulated as such, said Debora Spar, author of The Baby Business, a detailed study of economics and market behaviour in treatment for infertility.

    Clinics should be obliged to provide information …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL